TAS-102 Adverse events compared to other approved flouropyrmidines - 101967

Spotlight
Video

TAS-102 Adverse events compared to other approved flouropyrmidines

Loading........
Description: Alan P. Venook, MD of University of California San Francisco discusses TAS-102 Adverse events compared to other approved flouropyrmidines at ASCO GI 2016
Shared By : Gastrointestinal-Cancer-Meeting
Posted on : 01/27/16
Added : 3 years ago